Washington, DC: Food and Drug Administration [FDA], 2010 January 13: ? p. [Online]. Accessed: http://www.regulations.gov [2010 February 15]
Showing items related by title, author, creator and subject.
Center for Biologics Evaluation and Research (United States) [CBER] (1998-07-01)
Regulatory Issues: Guidance for Industry -- Guidance for Human Somatic Cell Therapy and Gene Therapy: March 1998 United States. Food and Drug Administration. Center for Biologics Evaluation and Research (1998-07-01)
Guidance for Industry: Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors Center for Biologics Evaluation and Research [CBER] (United States) (2001-02-10)